Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 45: 901-904, 1999;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (36)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benzie, I. F.F.
Right arrow Articles by Tomlinson, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benzie, I. F.F.
Right arrow Articles by Tomlinson, B.
Related Collections
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 1999;45:901-904.)
© 1999 American Association for Clinical Chemistry, Inc.


Technical Briefs

Simultaneous Measurement of Allantoin and Urate in Plasma: Analytical Evaluation and Potential Clinical Application in Oxidant:Antioxidant Balance Studies

Iris F.F. Benzie1,a, Wai-yuen Chung1 and Brian Tomlinson2

1 Department of Nursing and Health Sciences, The Hong Kong Polytechnic University, Kowloon, Hong Kong SAR, China;
2 Division of Clinical Pharmacology, The Chinese University of Hong Kong, New Territories, Hong Kong SAR, China;
a author for correspondence: fax (0)852-23649663, e-mail hsbenzie@polyu.edu.hk

In humans, allantoin is formed by nonenzymatic oxidation of urate; it may, therefore, be useful in assessing oxidative stress(1)(2). Most published methods involve separate analysis of urate and allantoin and require extraction, hydrolysis, and derivatization procedures (1)(2)(3)(4)(5)(6). The primary aim of this study was to evaluate a slightly modified version of an HPLC assay described by Lux et al. (7) for the simultaneous measurement of urate and allantoin. A secondary aim was to explore the clinical utility of allantoin as a biomarker of oxidative stress, the hypothesis being that in disease associated with increased oxidative stress, allantoin increases because of an increased "oxidative turnover" of urate. The final aim of the study was to investigate the effect of age on urate and allantoin concentrations.

Allantoin and uric acid were from Sigma; 1-heptanesulfonic acid, sodium salt monohydrate was from Sigma-Aldrich; potassium dihydrogen phosphate was from Merck; sodium hydroxide was from Riedel-de Haen; orthophosphoric acid was from BDH, and Moni-Trol Level 1 Chemistry Control Serum was from Dade International. MilliQ water (Millipore ultra-pure water system; Millipore) was used for preparation of all solutions. Aqueous stock solutions of allantoin (1000 µmol/L) and urate (2000 µmol/L) were prepared and stored at 4 °C. Because uric acid (urate) is more soluble at alkaline pH, sodium hydroxide (1 mol/L) was added dropwise until the pH was ~9.0; at this pH, all urate was dissolved. Calibrators (10–100 µmol/L for allantoin; 50–1000 µmol/L for urate) were prepared in mobile phase from stock solutions: 25 µL of each calibrator was mixed with 25 µL of Moni-Trol control serum and 75 µL of mobile phase. Ultrafiltrates (see below) of diluted calibrators were used to construct daily calibration curves. For precision studies, we . . . [Full Text of this Article]


Acknowledgments


References




The following articles in journals at HighWire Press have cited this article:


Home page
ICVTSHome page
W. B. Gerritsen, W.-J. P. van Boven, D. S. Boss, F. J. Haas, E. P. van Dongen, and L. P. Aarts
Malondialdehyde in plasma, a biomarker of global oxidative stress during mini-CABG compared to on- and off-pump CABG surgery: a pilot study
Interactive CardioVascular and Thoracic Surgery, February 1, 2006; 5(1): 27 - 31.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
H.-C. Chou, C.-Z. Lee, L.-C. Ma, C.-T. Fang, S.-C. Chang, and J.-T. Wang
Isolation of a Chromosomal Region of Klebsiella pneumoniae Associated with Allantoin Metabolism and Liver Infection
Infect. Immun., July 1, 2004; 72(7): 3783 - 3792.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
W J van Boven, W B Gerritsen, F G Waanders, F J Haas, and L P Aarts
Mini extracorporeal circuit for coronary artery bypass grafting: initial clinical and biochemical results: A comparison with conventional and off-pump coronary artery bypass grafts concerning global oxidative stress and alveolar function
Perfusion, July 1, 2004; 19(4): 239 - 246.
[Abstract] [PDF]


Home page
DiabetesHome page
S. Kopprasch, J. Pietzsch, E. Kuhlisch, K. Fuecker, T. Temelkova-Kurktschiev, M. Hanefeld, H. Kuhne, U. Julius, and J. Graessler
In Vivo Evidence for Increased Oxidation of Circulating LDL in Impaired Glucose Tolerance
Diabetes, October 1, 2002; 51(10): 3102 - 3106.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. Doehner, N. Schoene, M. Rauchhaus, F. Leyva-Leon, D. V. Pavitt, D. A. Reaveley, G. Schuler, A. J.S. Coats, S. D. Anker, and R. Hambrecht
Effects of Xanthine Oxidase Inhibition With Allopurinol on Endothelial Function and Peripheral Blood Flow in Hyperuricemic Patients With Chronic Heart Failure: Results From 2 Placebo-Controlled Studies
Circulation, June 4, 2002; 105(22): 2619 - 2624.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
L. S. Tam, E. K. Li, I. F. F. Benzie, C. W. K. Lam, M. Arumanayagam, W. Y. Chung, and B. Tomlinson
Metabolic abnormalities associated with microalbuminuria in systemic lupus erythematosus
Rheumatology, October 1, 2001; 40(10): 1193 - 1194.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Association for Clinical Chemistry.